Updates are available Correction dated 2024-10-14
Click to view Correction: https://doi.org/10.1186/s13024-024-00763-3
-
Authors
Wang, Hui
Chang, Timothy S.
Dombroski, Beth A.
Cheng, Po-Liang
Patil, Vishakha
Valiente-Banuet, Leopoldo
Farrell, Kurt
Mclean, Catriona
Molina-Porcel, Laura
Rajput, Alex
De Deyn, Peter Paul
Le Bastard, Nathalie
Gearing, Marla
Kaat, Laura Donker
Van Swieten, John C.
Dopper, Elise
Ghetti, Bernardino F.
Newell, Kathy L.
Troakes, Claire
de Yébenes, Justo G.
Rábano-Gutierrez, Alberto
Meller, Tina
Oertel, Wolfgang H.
Respondek, Gesine
Stamelou, Maria
Arzberger, Thomas
Roeber, Sigrun
Müller, Ulrich
Hopfner, Franziska
Pastor, Pau
Brice, Alexis
Durr, Alexandra
Le Ber, Isabelle
Beach, Thomas G.
Serrano, Geidy E.
Hazrati, Lili-Naz
Litvan, Irene
Rademakers, Rosa
Ross, Owen A.
Galasko, Douglas
Boxer, Adam L.
Miller, Bruce L.
Seeley, Willian W.
Van Deerlin, Vivanna M.
Lee, Edward B.
White, Charles L. III
Morris, Huw
de Silva, Rohan
Crary, John F.
Goate, Alison M.
Friedman, Jeffrey S.
Leung, Yuk Yee
Coppola, Giovanni
Naj, Adam C.
Wang, Li-San
,
Dalgard, Clifton
Dickson, Dennis W.
Höglinger, Günter U.
Schellenberg, Gerard D.
Geschwind, Daniel H.
Lee, Wan-Ping https://orcid.org/0000-0002-5305-1181
-
Funding
Funding for this research was provided by:
NIH (RF1-AG074328, 5UG3NS104095)
Rainwater Charitable Foundation
CurePSP
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 22 July 2024
First Online: 16 August 2024
Change Date: 14 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13024-024-00763-3
Declarations
:
: Not applicable.
: Laura Molina-Porcel received income from Biogen as a consultant in 2022. Gesine Respondek is now employed by Roche (Hoffmann-La Roche, Basel, Switzerland) since 2021. Her affiliation whilst completing her contribution to this manuscript was German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. Thomas G Beach is a consultant for Aprinoia Therapeutics and a Scientific Advisor and stock option holder for Vivid Genomics. Huw Morris is employed by UCL. In the last 12 months he reports paid consultancy from Roche, Aprinoia, AI Therapeutics and Amylyx; lecture fees/honoraria—BMJ, Kyowa Kirin, Movement Disorders Society. Huw Morris is a co-applicant on a patent application related to C9ORF72—Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140). Giovanni Coppola is currently an employee of Regeneron Pharmaceuticals. Alison Goate serves on the SAB for Genentech and Muna Therapeutics.
